文献速递肺外科

非小细胞肺癌初始非手术治疗后行肺切除术的结局与预后因素

Lung resection after initial nonoperative treatment for non-small cell lung cancer.
PubMed 文献 · J Thorac Cardiovasc Surg · 2023-11-30

本研究基于单中心前瞻性数据库,纳入2010至2022年间初始非手术治疗后行肺切除术的非小细胞肺癌患者120例,评估手术结局及生存相关预后因素。结果显示3级及以上并发症发生率为5%,90天死亡率为3%,3年无事件生存率和总生存率分别为39%和73%。IV期患者接受挽救性肺切除的总生存优于仅接受后续系统治疗未手术的相似患者。

要点

  • 初始非手术治疗后行肺切除术的3年无事件生存率为39%,总生存率为73%。
  • 3级及以上并发症发生率为5%,90天死亡率为3%。
  • 男性性别和淋巴血管侵犯与较短的无事件生存和总生存相关。

核心结论

  • 在这一经过选择的异质性人群中,非小细胞肺癌初始非手术治疗后行肺切除术是安全的。
  • 作为局部巩固治疗的 surgery 与令人鼓舞的结局相关,作者认为应考虑用于这些患者。

研究设计与样本

  • 单中心前瞻性维护数据库识别2010至2022年间初始非手术治疗后接受手术的患者。
  • 排除标准包括异时性癌症、计划的新辅助治疗以及以诊断或姑息为目的的手术。
  • 共120例患者符合纳入标准,构建Cox模型分析总生存和无事件生存。
  • 将IV期患者的生存与未接受手术的非研究队列进行比较。

主要发现

  • 初始临床分期为早期者占16%,局部区域晚期者占25%,转移性者占59%。
  • 手术指征为复发者占18%,局部持续病变者占23%,寡进展者占22%,寡转移性疾病局部控制者占38%。
  • 3级及以上并发症发生率为5%,90天死亡率为3%。
  • 3年无事件生存率为39%,总生存率为73%。
  • 男性性别和淋巴血管侵犯与较短的无事件生存和总生存相关;较年轻年龄和既往放疗与较短的总生存相关。

临床怎么用

  • 作者认为,对于经过选择的初始非手术治疗后的非小细胞肺癌患者,可考虑将手术作为局部巩固治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The study objectives were to assess the outcomes of lung resection in patients with non-small cell lung cancer previously treated with nonoperative treatment and to identify prognostic factors associated with survival. METHODS: Patients who underwent surgery (2010-2022) after initial nonoperative treatment at a single institution were identified from a prospectively maintained database. Exclusion criteria included metachronous cancer, planned neoadjuvant therapy, and surgery for diagnostic or palliative indications. Cox models were constructed for overall survival and event-free survival. Survival of patients with stage IV disease was compared with survival of a nonstudy cohort who did not undergo surgery. RESULTS: In total, 120 patients met the inclusion criteria. Initial clinical stage was early stage in 16%, locoregionally advanced in 25%, and metastatic in 59% of patients. The indication for surgery was recurrence in 18%, local persistent disease in 23%, oligoprogression in 22%, and local control of oligometastatic disease in 38% of patients. Grade 3 or greater complications occurred in 5% of patients; 90-day mortality was 3%. Three-year event-free survival and overall survival were 39% and 73%, respectively. Male sex and lymphovascular invasion were associated with shorter event-free survival and overall survival; younger age and prior radiation therapy were associated with shorter overall survival. Patients with stage IV disease who received salvage lung resection had better overall survival than similar patients who received subsequent systemic therapy and no surgery. CONCLUSIONS: In this selected, heterogeneous population, lung resection after initial nonoperative treatment for non-small cell lung cancer was safe. Surgery as local consolidative therapy was associated with encouraging outcomes and should be considered for these patients.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Dunne EG, Fick CN, Tan KS, et al. Lung resection after initial nonoperative treatment for non-small cell lung cancer. J Thorac Cardiovasc Surg. 2023. PMID: 38042400. doi:10.1016/j.jtcvs.2023.11.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。